nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—adrenal gland—polycystic ovary syndrome	0.0929	0.536	CbGeAlD
Bisacodyl—GPR55—endocrine gland—polycystic ovary syndrome	0.0805	0.464	CbGeAlD
Bisacodyl—GPR55—GPCRs, Other—ADRA1D—polycystic ovary syndrome	0.0425	0.0514	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—FSHR—polycystic ovary syndrome	0.0342	0.0414	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—NPB—polycystic ovary syndrome	0.0262	0.0317	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—PTGER3—polycystic ovary syndrome	0.0219	0.0265	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.0209	0.0252	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.0174	0.0211	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.0174	0.0211	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.0163	0.0197	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.0163	0.0197	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—NPB—polycystic ovary syndrome	0.0159	0.0192	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.0158	0.0191	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.0154	0.0186	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.0133	0.016	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.0133	0.016	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.0127	0.0154	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.0125	0.0151	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.0124	0.015	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.012	0.0146	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.0117	0.0142	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.0117	0.0141	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.0112	0.0136	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.0111	0.0134	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.0108	0.0131	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00991	0.012	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.0097	0.0117	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00897	0.0109	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00887	0.0107	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00854	0.0103	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00844	0.0102	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00825	0.00998	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00815	0.00986	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00812	0.00982	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00795	0.00961	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00795	0.00961	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00791	0.00957	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00754	0.00913	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00749	0.00906	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00749	0.00906	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00737	0.00892	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00732	0.00885	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00706	0.00854	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00701	0.00848	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0068	0.00823	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0068	0.00823	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.0068	0.00823	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00662	0.008	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00636	0.0077	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00618	0.00747	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00606	0.00733	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00602	0.00728	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00601	0.00727	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00557	0.00674	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00551	0.00666	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00548	0.00663	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00547	0.00661	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00501	0.00607	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00498	0.00602	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00483	0.00584	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NPB—polycystic ovary syndrome	0.00481	0.00582	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00477	0.00577	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00476	0.00575	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00466	0.00564	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00461	0.00558	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00455	0.00551	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00447	0.00541	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00438	0.0053	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00435	0.00527	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00433	0.00524	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00428	0.00517	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00426	0.00516	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00423	0.00512	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00406	0.00491	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00402	0.00486	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00402	0.00486	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00387	0.00468	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00378	0.00457	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00376	0.00455	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00365	0.00441	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00355	0.00429	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00346	0.00418	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00323	0.00391	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00315	0.00381	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00294	0.00356	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00288	0.00348	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00286	0.00346	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00277	0.00335	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00269	0.00325	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FST—polycystic ovary syndrome	0.00262	0.00317	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00261	0.00315	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00259	0.00313	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LHB—polycystic ovary syndrome	0.00256	0.0031	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.0025	0.00303	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00242	0.00293	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00242	0.00292	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SCT—polycystic ovary syndrome	0.0024	0.0029	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00237	0.00286	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00229	0.00277	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00225	0.00272	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00223	0.0027	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00219	0.00266	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00208	0.00252	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00205	0.00248	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—INSR—polycystic ovary syndrome	0.00196	0.00237	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00186	0.00226	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00184	0.00222	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PGR—polycystic ovary syndrome	0.00182	0.0022	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00169	0.00204	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00169	0.00204	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00163	0.00197	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00161	0.00195	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00157	0.0019	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00156	0.00189	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00149	0.0018	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00148	0.00179	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PRL—polycystic ovary syndrome	0.00147	0.00178	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00142	0.00172	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.0014	0.00169	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNAS—polycystic ovary syndrome	0.0013	0.00157	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00124	0.00149	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00121	0.00147	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00104	0.00126	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LEP—polycystic ovary syndrome	0.00102	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000907	0.0011	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—POMC—polycystic ovary syndrome	0.000873	0.00106	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—INS—polycystic ovary syndrome	0.000868	0.00105	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00084	0.00102	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000839	0.00102	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000797	0.000965	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000642	0.000777	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000548	0.000664	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6—polycystic ovary syndrome	0.000379	0.000459	CbGpPWpGaD
